OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Pharmacology is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Pharmacogenomics	399
The pathogenesis and development of targeted drugs in acute T lymphoblastic leukaemia	339
Issue Information	317
Identification and pre‐clinical investigation of 3‐O‐cyclohexanecarbonyl‐11‐keto‐β‐boswellic acid as a drug for external use to treat psoriasis	213
Alpha 7‐nicotinic cholinoceptor regulation of pericyte‐containing retinal capillaries	198
Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium	179
	165
	150
Issue Information	144
The respiratory depressant effects of mitragynine are limited by its conversion to 7‐OH mitragynine	140
Spontaneous and pharmacologically induced hypothermia protect mice against endotoxic shock	123
Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2‐positive breast cancer	118
A vitamin D‐based strategy overcomes chemoresistance in prostate cancer	115
Repurposing cyclovirobuxine D as a novel inhibitor of colorectal cancer progression via modulating the CCT3/YAP axis	112
Ticagrelor inverse agonist activity at the P2Y₁₂ receptor is non‐reversible versus its endogenous agonist adenosine 5´‐diphosphate	101
Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta‐analysis of variance	100
Opportunities of patient‐derived organoids in drug development	99
Chemosensory signalling in human sperm is controlled by Ca²⁺ influx via CatSper and Ca²⁺ clearance via plasma membrane Ca²⁺ ATPases	92
EXPRESSION OF CONCERN: Rosiglitazone and 15‐deoxy‐Δ^12,14‐prostaglandin J₂, ligands of the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), reduce ischaemia/reperfusion inju	88
RETRACTION: Cloricromene, a Coumarine Derivative, Protects Against Collagen‐induced Arthritis in Lewis Rats	87
A bio. tools collection of online resources for GPCR research	83
SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokines	82
2‐Hydroxyl hispolon reverses high glucose‐induced endothelial progenitor cell dysfunction through the PI3K/Akt/eNOS and AMPK/HO‐1 pathways	81
Endothelium‐derived hydrogen sulfide acts as a hyperpolarizing factor and exerts neuroprotective effects via activation of large‐conductance Ca²⁺‐activated K⁺ channels	76
Early erythroferrone levels can predict the long‐term haemoglobin responses to erythropoiesis‐stimulating agents	76

Low molecular weight fucoidan restores diabetic endothelial glycocalyx by targeting neuraminidase2: A new therapy target in glycocalyx shedding	74
Targeting Na⁺/K⁺‐ATPase by berbamine and ouabain synergizes with sorafenib to inhibit hepatocellular carcinoma	73
Compulsive alcohol seeking and relapse: Central role of conditioning factors associated with alleviation of withdrawal states by alcohol	72
Silencing drug transporters in human primary muscle cells modulates atorvastatin pharmacokinetics: A pilot study	70
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome	66
Mitragynine (Kratom)—Withdrawal behaviour and cognitive impairments can be ameliorated by an epigenetic mechanism	66
The Concise Guide to PHARMACOLOGY 2023/24: Nuclear hormone receptors	66
Asthma: role of the angiotensin‐(1‐7)/Mas (MAS1) pathway in pathophysiology and therapy	64
The Concise Guide to PHARMACOLOGY 2023/24: Ion channels	64
P2Y₁₄ receptor activation of platelets induces Ca²⁺ mobilization and Rho‐GTPase‐dependent motility that requires an interaction with P2Y₁ receptors	62
No new ‘mabs’ in medicine—New nomenclature for monoclonal antibodies	62
Pentoxifylline as a therapeutic option for pre‐eclampsia: a study on its placental effects	62
Issue Information	60
Withdrawal: Ham, H. J., Lee, Y. S., Lee, H. P., Cho, J., Ham, Y. W., Lee, K. S., Yun, J., Han, S. B. and Hong, J. T. G721‐0282 exerts anxiolytic‐like effects on chronic unpredictable mild stres	56
Assessment of Spinster homologue 2 (Spns2)‐dependent transport of sphingosine‐1‐phosphate as a therapeutic target	55
Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models	54
Optical control of cardiac electrophysiology by the photochromic ligand azobupivacaine 2	53
Issue Information	53
The endocannabinoid anandamide mediates anti‐inflammatory effects through activation of NR4A nuclear receptors	53
Cross‐pathway integration of cAMP signals through cGMP and calcium‐regulated phosphodiesterases in mouse striatal cholinergic interneurons	52
Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice	52
NaHS alters synaptic plasticity proteins and enhances dendritic arborization to improve cognitive and motor deficits after traumatic brain injury in mice	50
S1P/S1PRs‐TRPV4 axis is a novel therapeutic target for persistent pain and itch in chronic dermatitis	49
Dopaminergic signalling and behavioural alterations by Comt–Dtnbp1 genetic interaction and their clinical relevance	48
	48